UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000049965
Receipt number R000056908
Scientific Title Real diagnostic ability of endoscopic ultrasound-guided fine needle aspiration for small pancreatic cancer 10mm and additional salvage by pancreatic juice cytology
Date of disclosure of the study information 2023/01/05
Last modified on 2023/01/05 15:11:13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Real diagnostic ability of endoscopic ultrasound-guided fine needle aspiration for small pancreatic cancer 10mm and additional salvage by pancreatic juice cytology

Acronym

Diagnostic ability of EUS-FNAB for small pancreatic cancer 10mm and additional salvage by pancreatic juice cytology

Scientific Title

Real diagnostic ability of endoscopic ultrasound-guided fine needle aspiration for small pancreatic cancer 10mm and additional salvage by pancreatic juice cytology

Scientific Title:Acronym

Diagnostic ability of EUS-FNAB for small pancreatic cancer 10mm and additional salvage by pancreatic juice cytology

Region

Japan


Condition

Condition

pancreatic tumor within 10mm in diameter

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Technical success and diagnostic rate of EUS-FNAB for pancreatic cancer within 10mm in diameter

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Technical success and diagnostic rate of EUS-FNAB for pancreatic cancer within 10mm in diameter

Key secondary outcomes

Additional diagnostic ability of pancreatic juice cytology
Procedure related factors affecting accurate EUS-FNAB diagnosis


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

95 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients with pancreatic tumor within 10mm in diameter by EUS during study period.

Key exclusion criteria

patients with pancreatic tumors more than 10mm in diameter by EUS.
patients with pancreatic metastasis from the other organ cancer/pancreatic malignant lymphoma/nodules in pancreatic cystic lesion

Target sample size

250


Research contact person

Name of lead principal investigator

1st name Ryota
Middle name
Last name Sagami

Organization

Department of Gastroenterology, Oita San-ai Medical Center, Oita, Japan
Department of Gastroenterology, Faculty of Medicine, Oita University, Oita, Japan

Division name

Department of Gastroenterology

Zip code

870-1151

Address

1213 Ichi, Oita, Oita, Japan

TEL

0975411311

Email

sagami1985@yahoo.co.jp


Public contact

Name of contact person

1st name Ryota
Middle name
Last name Sagami

Organization

Oita San-ai Medical Center

Division name

Department of Gastroenterology

Zip code

8701151

Address

1213 Ichi, Oita, Japan

TEL

0975411311

Homepage URL


Email

sagami1985@yahoo.co.jp


Sponsor or person

Institute

Oita San-ai Medical Center

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital
Tenri Hospital
Kindai University

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Oita San-ai Medical Center

Address

1213 Ichi, Oita, Oita

Tel

0975411311

Email

sagami1985@yahoo.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大分三愛メディカルセンター (大分),東京都立駒込病院(東京都),天理病院(奈良県),近大病院(大阪府)


Other administrative information

Date of disclosure of the study information

2023 Year 01 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2023 Year 01 Month 05 Day

Date of IRB

2022 Year 01 Month 21 Day

Anticipated trial start date

2023 Year 01 Month 05 Day

Last follow-up date

2025 Year 01 Month 05 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2023 Year 01 Month 05 Day

Last modified on

2023 Year 01 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056908